Thibaut Santiard Email

Head Finance, EU . Correvio International Sàrl

Current Roles

Employees:
0
Revenue:
$0
About
About us Correvio International is a privately held pharmaceutical company located in Geneva, Switzerland. Correvio LLC, our global supply chain operation, is located in Chester, Pennsylvania, USA. Currently, we commercialise Aggrastat® (tirofiban HCl)* in more than 50 countries worldwide either directly (Europe) or via our distributor and partner network. Our aim We strive to help healthcare professionals improve outcomes for critically ill patients, currently in the field of Acute Coronary Syndromes (ACS). Our dedicated teams of employees offer considerable knowledge and experience and a shared goal of finding the right therapy for the right patient. Our product Aggrastat® is a reversible GP IIb/IIIa inhibitor for use in indicated Acute Coronary Syndrome patients. Aggrastat® is used to treat more than 250,000 patients annually and Correvio measures its business success in terms of Major Adverse Cardiac Events (MACE) prevented (approximately 18,000 MACE annually). Our services Core to our business is our multi-lingual 24/7/365 Medical Information Center and our contemporary medical education tools and services.
Correvio International Sàrl Address
5 Christy Drive
Geneva, null
United States
Correvio International Sàrl Email
Correvio International Sàrl Phone Numbers
610-833-6050

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.